Larvol Delta - Comparison-of-the-Pharmacokinetics-PK-and-Pharmacodynamics-PD-Biosimilarity-of-Proposed-Biosimilar-RapidActing-Insulin-Aspart-I004-and-NovoLog-After-SingleDose-Subcutaneous-Administration-to-Healthy-Volunteers

NovoLog (insulin aspart) - Novo Nordisk

I004 (insulin aspart rapid-acting biosimilar) - Amphastar

http://clinicaltrials.gov/ct2/show/NCT05539872

Sep 14, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next